310 related articles for article (PubMed ID: 12527987)
1. GM2 gangliosidosis variant B1 neuroradiological findings.
Grosso S; Farnetani MA; Berardi R; Margollicci M; Galluzzi P; Vivarelli R; Morgese G; Ballestri P
J Neurol; 2003 Jan; 250(1):17-21. PubMed ID: 12527987
[TBL] [Abstract][Full Text] [Related]
2. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
[TBL] [Abstract][Full Text] [Related]
3. Natural History of Adult Patients with GM2 Gangliosidosis.
Masingue M; Dufour L; Lenglet T; Saleille L; Goizet C; Ayrignac X; Ory-Magne F; Barth M; Lamari F; Mandia D; Caillaud C; Nadjar Y
Ann Neurol; 2020 Apr; 87(4):609-617. PubMed ID: 31995250
[TBL] [Abstract][Full Text] [Related]
4. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis.
Rowe OE; Rangaprakash D; Weerasekera A; Godbole N; Haxton E; James PF; Stephen CD; Barry RL; Eichler FS; Ratai EM
Mol Genet Metab; 2021 Aug; 133(4):386-396. PubMed ID: 34226107
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset.
Kern J; Böhringer J; Timmann D; Trollmann R; Stendel C; Kamm C; Röbl M; Santhanakumaran V; Groeschel S; Beck-Wödl S; Göricke S; Krägeloh-Mann I; Synofzik M
Neurology; 2024 Jan; 102(1):e207898. PubMed ID: 38165373
[TBL] [Abstract][Full Text] [Related]
7. Newly observed thalamic involvement and mutations of the HEXA gene in a Korean patient with juvenile GM2 gangliosidosis.
Lee SM; Lee MJ; Lee JS; Kim HD; Lee JS; Kim J; Lee SK; Lee YM
Metab Brain Dis; 2008 Sep; 23(3):235-42. PubMed ID: 18648917
[TBL] [Abstract][Full Text] [Related]
8. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
9. Plasma G
Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
12. Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis.
Utsumi K; Tsuji A; Kase R; Tanaka A; Tanaka T; Uyama E; Ozawa T; Sakuraba H; Komaba Y; Kawabe M; Iino Y; Katayama Y
Acta Neurol Scand; 2002 Jun; 105(6):427-30. PubMed ID: 12027830
[TBL] [Abstract][Full Text] [Related]
13. [GM2 gangliosidosis].
Tsuji S
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):177-9. PubMed ID: 10434623
[No Abstract] [Full Text] [Related]
14. Juvenile GM2 gangliosidosis variant B1: clinical and biochemical study in seven patients.
Maia M; Alves D; Ribeiro G; Pinto R; Sa Miranda MC
Neuropediatrics; 1990 Feb; 21(1):18-23. PubMed ID: 2138256
[TBL] [Abstract][Full Text] [Related]
15. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene.
Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M
J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755
[TBL] [Abstract][Full Text] [Related]
16. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
Pampiglione G; Harden A
Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
[TBL] [Abstract][Full Text] [Related]
17. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.
Májovská J; Hennig A; Nestrasil I; Schneider SA; Jahnová H; Vaněčková M; Magner M; Dušek P
Neurol Sci; 2022 May; 43(5):3273-3281. PubMed ID: 34800199
[TBL] [Abstract][Full Text] [Related]
18. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in molecular genetics of GM2 gangliosidosis].
Wakamatsu N
Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of early juvenile GM2 gangliosidosis: a case report].
Ono H; Sugiura C; Narita A; Ohno K; Saito Y; Maegaki Y; Murakami N; Nanba E
No To Hattatsu; 2017 May; 49(3):203-6. PubMed ID: 30113798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
